• In late July 2026, Oracle and Google Cloud expanded their partnership to bring Google's Gemini AI models into Oracle Fusion Applications, NetSuite and the AI Agent Studio, deepening multi-model AI capabilities across Oracle’s enterprise software stack.
• This collaboration gives Oracle customers and partners broader choice of advanced AI models for building agents and automation, potentially tightening the link between Oracle’s core business applications and next-generation AI tools.
• Next, we’ll examine how integrating Google’s Gemini models into Oracle’s applications could influence the company’s AI-led investment narrative.

Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

Oracle Investment Narrative Recap

To own Oracle today, you need to believe its aggressive AI and cloud buildout can translate a large backlog into profitable, recurring revenue faster than its heavy US$70,000 million-plus capex plan pressures margins. The expanded Google Gemini integration reinforces Oracle’s pitch that its AI-infused applications can deepen customer stickiness, but it does not materially change the near term risk that AI infrastructure demand from a few large customers could soften or ramp more slowly than expected.

The recent 10 year, up to US$6,990 million Department of War Enterprise Software Initiative contract looks especially relevant here. It showcases how Oracle’s cloud, database and applications can be bundled into long duration agreements that help underpin its AI and infrastructure spending plans, even as investors weigh how quickly these types of commitments convert into revenue and cash flow.

Yet while the AI story is appealing, investors should also be aware that Oracle’s unprecedented capex ramp could still leave it exposed if...

Oracle's narrative projects $181.8 billion revenue and $41.7 billion earnings by 2029. This requires 39.2% yearly revenue growth and a $24.7 billion earnings increase from $17.0 billion today.

Uncover how Oracle's forecasts yield a $248.15 fair value, a 91% upside to its current price.

Exploring Other Perspectives

Compared with the consensus view, the most optimistic analysts were already banking on Oracle lifting revenue to about US$196,600 million by 2029, so the Gemini news could either reinforce that bullish AI backlog story or highlight how dependent those forecasts are on rapid follow through from deals like this.

Explore 29 other fair value estimates on Oracle - why the stock might be worth over 3x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Oracle research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Oracle research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Oracle's overall financial health at a glance.

Want Some Alternatives?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.